Ernexa Therapeutics Inc (ERNA) Stock Price, Quote, News & History

ERNANASDAQ
$6.42
-0.70-9.83%
At close: Jul 17, 5:00 PM EST
$6.40
-0.02-0.31%
After Hours: 5:54 PM EST
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-7.22M
Investing Cash Flow (TTM)
-39.00K
Financing Cash Flow (TTM)
14.51M
Free Cash Flow (TTM)
-7.26M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
7.26M

Analyst Trends and Forecast

1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$1.25M
PE Ratio (TTM)
0.01
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.21
Earnings Yield % (TTM)
-72.89%
Earnings Yield % (FWD)
-264.75%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.88

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-
Total Cash
$9.18M
Debt to Equity
0.06
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
-

Key Statistics

Open
$6.95
Close
$6.42
Volume / Avg.
117.83K / 2.04M
Day Range
$6.42 - $7.21
52 Wk Range
3.18 - 71.50
Market Cap
$7.46M
P/E Ratio
0.01
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
4%
Days to Cover
1

About

Sector
Health Care
Industry
Biotechnology
Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Ernexa Therapeutics (ERNA) stock?

A

You can purchase shares of Ernexa Therapeutics (NASDAQ:ERNA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Ernexa Therapeutics (ERNA) competitors?

A

There are no as such competitors for Ernexa Therapeutics.

Q

What is the forecast, or price target, for Ernexa Therapeutics (ERNA) stock?

A

Ernexa Therapeutics has a consensus price target of $30.00.

Q

What is the current price for Ernexa Therapeutics (ERNA)?

A

The stock price for Ernexa Therapeutics (NASDAQ: ERNA) is $6.4 last updated July 17, 2026 at 5:54 PM EDT.

Q

Does Ernexa Therapeutics (ERNA) pay a dividend?

A

There are no upcoming dividends for Ernexa Therapeutics.

Q

When is Ernexa Therapeutics (NASDAQ:ERNA) reporting earnings?

A

Ernexa Therapeutics does not have any upcoming earnings scheduled.

Q

Is Ernexa Therapeutics (ERNA) going to split?

A

There is no upcoming split for Ernexa Therapeutics.

Q

What sector and industry does Ernexa Therapeutics (ERNA) operate in?

A

Ernexa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.